Progyny Inc. (PGNY)
21.88
-0.43 (-1.93%)
At close: Mar 28, 2025, 3:59 PM
21.83
-0.23%
After-hours: Mar 28, 2025, 05:18 PM EDT
Progyny Income Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | 1.17B | 1.09B | 786.91M | 500.62M | 344.86M | 229.68M | 105.4M | 48.58M |
Cost of Revenue | 913.86M | 849.8M | 619.59M | 388.49M | 274.8M | 184.18M | 85.97M | 41.18M |
Gross Profit | 253.36M | 238.8M | 167.32M | 112.14M | 70.06M | 45.51M | 19.43M | 7.4M |
Operating Income | 67.45M | 62.18M | 23.34M | 32.34M | 8.35M | 27.85M | -3.45M | -11.01M |
Interest Income | 15.75M | n/a | 814K | 461K | 121K | 58K | n/a | n/a |
Pretax Income | 83.2M | 70.69M | 24.44M | 32.44M | 8.68M | -8.56M | -6.89M | -12.46M |
Net Income | 54.34M | 62.04M | 30.36M | 65.77M | 46.46M | -8.57M | 661K | -12.45M |
Selling & General & Admin | 185.91M | 176.62M | 143.98M | 79.8M | 61.71M | 35.83M | 22.89M | 18.41M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | 286K | -366K | 210K | n/a | n/a | n/a |
Operating Expenses | 185.91M | 176.62M | 143.98M | 79.8M | 61.71M | 35.83M | 22.89M | 18.41M |
Interest Expense | n/a | n/a | 814K | 461K | 121K | 58K | n/a | n/a |
Selling & Marketing Expenses | 63.95M | 59.49M | 45.66M | 20.18M | 15.01M | 11.9M | 7.29M | 4.26M |
Cost & Expenses | 1.1B | 1.03B | 763.57M | 468.28M | 336.51M | 220.01M | 108.85M | 59.59M |
Income Tax | 28.87M | 8.65M | -5.92M | -33.33M | -37.78M | 12K | -1.78M | -3K |
Shares Outstanding (Basic) | 91.48M | 95.02M | 92.2M | 89.11M | 85.72M | 83.57M | 81.56M | 70.59M |
Shares Outstanding (Diluted) | 95.45M | 100.67M | 99.96M | 100.36M | 99.06M | 83.57M | 81.56M | 81.56M |
EPS (Basic) | 0.59 | 0.65 | 0.33 | 0.74 | 0.54 | -0.1 | 0.01 | -0.18 |
EPS (Diluted) | 0.57 | 0.62 | 0.30 | 0.66 | 0.47 | -0.1 | 0.01 | -0.15 |
EBITDA | 67.45M | 64.47M | 24.94M | 33.64M | 10.25M | 11.81M | -1.57M | -9.45M |
Depreciation & Amortization | n/a | 2.28M | 1.6M | 1.3M | 1.91M | 2.13M | 1.88M | 1.56M |